Crescent Biopharma, Inc.
CBIO
Positions held
Your positionsCBIO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $524.51M | Enterprise value | $438.19M | Trailing P/E | — | Forward P/E | -5.37 |
| PEG | — | Price / book | 2.96 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 100.0% | Operating margin | -14.3% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 0.01 |
| Current ratio | 9.66 | Free cash flow | — | Analyst recommendation | strong_buy | Mean target | $31.50 |
| 52w high | $27.41 | 52w low | $8.72 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $1.0M | $10.8M | $0.0M | $0.0M |
| Op margin | — | -2380.1% | -843.7% | — | — |
| Net income | -$24.8M | -$23.3M | -$92.4M | -$24.6M | -$21.8M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$26.4M | -$24.7M | -$91.5M | -$25.9M | -$21.0M |
- Revenue -100% vs prior quarter ($0 vs $1.0M).
- Operating margin compressed to -2380.1%.
Yearly (6y)
| 2025 | |
|---|---|
| Revenue | $10.8M |
| Op margin | -1407.5% |
| Net income | -$154M |
| Gross margin | — |
| Gross profit | — |
| Operating income | -$153M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Crescent Biopharma Announces Grants of Inducement Awards
2026-10-06 · HC Wainwright Upgrades Crescent Biopharma to Buy From Neutral, Price Target is $36
2026-10-05 · Crescent Biopharma's Investigational New Drug Application for CR-002 to Treat Solid Tumors Cleared by FDA
2026-09-25 · Crescent Biopharma Announces Grants of Inducement Awards
2026-09-14 · Crescent's Tumor Treatment Validated by Akeso Trial Results, Wedbush Says
2026-09-03 · Summit Packs A Punch For Merck's Keytruda — But Not Everyone Is Sold
2026-09-03 · Crescent Biopharma to Present at September Investor Conferences
2026-08-03 · Crescent Biopharma Announces Grants of Inducement Awards
2026-07-30 · Crescent Biopharma: Q2 Earnings Snapshot
2026-07-30 · Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
2026-07-23 · Crescent Biopharma Announces Grants of Inducement Awards
Price (daily)
Full chart · RSI · MACD · patterns